Development of Multigene and Regulated Lentivirus Vectors
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Previously we described safe and efficient three-component human immunodeficiency virus type 1 (HIV-1)-based gene transfer systems for delivery of genes into nondividing cells (H. Mochizuki, J. P. Schwartz, K. Tanaka, R. O. Brady, and J. Reiser, J. Virol. 72:8873–8883, 1998). To apply such vectors in anti-HIV gene therapy strategies and to express multiple proteins in single target cells, we have engineered HIV-1 vectors for the concurrent expression of multiple transgenes. Single-gene vectors, bicistronic vectors, and multigene vectors expressing up to three exogenous genes under the control of two or three different transcriptional units, placed within the viral gag-pol coding region and/or the viral nef and env genes, were designed. The genes encoding the enhanced version of green fluorescent protein (EGFP), mouse heat-stable antigen (HSA), and bacterial neomycin phosphotransferase were used as models whose expression was detected by fluorescence-activated cell sorting, fluorescence microscopy, and G418 selection. Coexpression of these reporter genes in contact-inhibited primary human skin fibroblasts (HSFs) persisted for at least 6 weeks in culture. Coexpression of the HSA and EGFP reporter genes was also achieved following cotransduction of target cells using two separate lentivirus vectors encoding HSA and EGFP, respectively. For the regulated expression of transgenes, tetracycline (Tet)-regulatable lentivirus vectors encoding the reverse Tet transactivator (rtTA) and EGFP controlled by a Tet-responsive element (TRE) were constructed. A binary HIV-1-based vector system consisting of a lentivirus encoding rtTA and a second lentivirus harboring a TRE driving the EGFP reporter gene was also designed. Doxycycline-modulated expression of the EGFP transgene was confirmed in transduced primary HSFs. These versatile vectors can potentially be used in a wide range of gene therapy applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903 · cited 2×
“Lentivirus vectors including HIV-1-based vectors, HIV-2-based vectors, simian immunodeficiency-based vectors, feline immunodeficiency virus-based vectors, and equine infectious anemia virus-based vectors are being increasingly used for gene delivery in vitro (2, 11, 16, 29, 32, 44, 46, 47, 49, 55, 58, 60, 62, 67, 68).”
BackgroundMethodA Third-Generation Lentivirus Vector with a Conditional Packaging System
Dull, T., Zufferey, R., Kelly, M., Mandel, R. J., Nguyen, M., Trono, D., & Naldini, L. (1998) · Journal of Virology · doi:10.1128/jvi.72.11.8463-8471.1998 · Cited by 3,341 · cited 1×
“Lentivirus vectors including HIV-1-based vectors, HIV-2-based vectors, simian immunodeficiency-based vectors, feline immunodeficiency virus-based vectors, and equine infectious anemia virus-based vectors are being increasingly used for gene delivery in vitro (2, 11, 16, 29, 32, 44, 46, 47, 49, 55, 58, 60, 62, 67, 68).”
MethodMultiply attenuated lentiviral vector achieves efficient gene delivery in vivo
Zufferey, R., Nagy, D., Mandel, R. J., Naldini, L., & Trono, D. (1997) · Nature Biotechnology · doi:10.1038/nbt0997-871 · Cited by 1,977 · cited 1×
“They are also promising for long-term gene expression in vivo in cells of the central nervous system (4, 5, 34, 46, 47, 69), hematopoietic system (42), retina (43), muscle and liver (30, 51), lung (23, 28), pancreatic islets (19), cochlea (24), and corneal tissue (66).”
BackgroundSelf-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery
Zufferey, R., Dull, T., Mandel, R. J., Bukovsky, A., Quiroz, D., Naldini, L., & Trono, D. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9873-9880.1998 · Cited by 1,815
Gene therapy - promises, problems and prospects
Verma, I. M., & Somia, N. (1997) · Nature · doi:10.1038/38410 · Cited by 1,681
Naldini, L., Blömer, U., Gage, F. H., Trono, D., & Verma, I. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11382 · Cited by 1,499 · cited 2×
“Lentivirus vectors including HIV-1-based vectors, HIV-2-based vectors, simian immunodeficiency-based vectors, feline immunodeficiency virus-based vectors, and equine infectious anemia virus-based vectors are being increasingly used for gene delivery in vitro (2, 11, 16, 29, 32, 44, 46, 47, 49, 55, 58, 60, 62, 67, 68).”
BackgroundMethodDevelopment of a self-inactivating lentivirus vector
Miyoshi, H., Blömer, U., Takahashi, M., Gage, F. H., & Verma, I. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8150-8157.1998 · Cited by 1,196 · cited 2×
“tors such as the adenovirus early protein E1A (41, 68).”
Background
Cited by
Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors
Kutner, R. H., Zhang, X.-Y., & Reiser, J. (2009) · Nature Protocols · doi:10.1038/nprot.2009.22 · Cited by 668
Self-citationGene delivery by lentivirus vectors
Cockrell, A. S., & Kafri, T. (2007) · Molecular Biotechnology · doi:10.1007/s12033-007-0010-8 · Cited by 355
Lentiviral Vectors in Gene Therapy: Their Current Status and Future Potential
Escors, D., & Breckpot, K. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-010-0063-4 · Cited by 344
“The tetracycline-based induction system is probably among the most widely used (Blomer et al. 1997; Gascon et al. 2008; Reiser et al. 2000; Seo et al. 2009; Vigna et al. 2002).”
Regulatable gene expression systems for gene therapy applications: progress and future challenges
Goverdhana, S., Puntel, M., Xiong, W., Zirger, J. M., Barcia, C., Curtin, J. F., Soffer, E. B., Mondkar, S., King, G. D., Hu, J., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.022 · Cited by 283
“In addition to single-gene-engineered lentiviral vectors, doxycycline-mediated regulation was also successfully attained from bicistronic lentiviral vectors, as demonstrated by Reiser and co-workers [144].”
BackgroundMethodDevelopment of 2A peptide-based strategies in the design of multicistronic vectors
Szymczak, A. L., & Vignali, D. A. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.5.627 · Cited by 283
Metadata
- Authors
- Reiser, J., Lai, Z., Zhang, X.-Y., & Brady, R. O.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2000-11-15
- Volume
- 74
- Issue
- 22
- Pages
- 10589-10599
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2129476172
- Cited by
- 120
- References
- 7
- FWCI
- 4.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Development of Multigene and Regulated Lentivirus Vectors. https://app.cochat.ai/papers/10.1128/jvi.74.22.10589-10599.2000
- The paper
- Reiser, J., Lai, Z., Zhang, X.-Y., & Brady, R. O. (2000). Development of Multigene and Regulated Lentivirus Vectors. Journal of Virology. https://doi.org/10.1128/jvi.74.22.10589-10599.2000
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.